Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-44,700
Closed -$99K 929
2022
Q3
$99K Hold
44,700
﹤0.01% 900
2022
Q2
$132K Hold
44,700
﹤0.01% 917
2022
Q1
$215K Hold
44,700
﹤0.01% 939
2021
Q4
$411K Hold
44,700
﹤0.01% 909
2021
Q3
$665K Hold
44,700
0.01% 865
2021
Q2
$735K Hold
44,700
0.01% 877
2021
Q1
$814K Sell
44,700
-308,200
-87% -$7.81M 0.01% 880
2020
Q4
$7.16M Buy
352,900
+92,900
+36% +$1.56M 0.06% 467
2020
Q3
$4.39M Buy
260,000
+59,400
+30% +$1.26M 0.05% 499
2020
Q2
$5.11M Buy
+200,600
New +$3.84M 0.06% 452

Other funds holding GAN

Royce & Associates's GAN Position: Q4 2022 in Review

Royce & Associates sold out of GAN Ltd (GAN) in Q4 2022, closing a stake of 44,700 shares — an estimated $99K sold.

Royce & Associates first reported a position in GAN in Q2 2020 and held it in 10 quarters. The position peaked at $7.16M in Q4 2020. 71 funds tracked by Wall St. Rank hold GAN as of Q4 2022.

  • Royce & Associates reported no remaining GAN Ltd position as of Q4 2022 after selling out during the quarter.
  • Royce & Associates sold 44,700 GAN Ltd shares in Q4 2022, an estimated $99K.
  • Royce & Associates first reported a position in GAN Ltd in Q2 2020 and held it in 10 quarters.
  • Royce & Associates's GAN Ltd position peaked at $7.16M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held GAN Ltd as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.